Shimadzu Europe
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
Clinical Laboratory int.
  • Allergies
  • Cardiac
  • Gastrointestinal
  • Hematology
  • Microbiology
  • Microscopy & Imaging
  • Molecular Diagnostics
  • Pathology & Histology
  • Protein Analysis
  • Rapid Tests
  • Therapeutic Drug Monitoring
  • Tumour Markers
  • Urine Analysis

Archive for category: E-News

E-News

cytena

CYTENA and ExcellGene to develop automated work-flows for biotherapeutics cell line development

, 16 May 2022/in E-News /by panglobal

CYTENA, a BICO group company and a leading provider of high-precision instruments for handling biological cells, will collaborate with ExcellGene, a leading biologics Contract Development & Manufacturing Organizations (CDMO) that manufactures recombinant proteins, to streamline cell line development workflows for highly-efficient monoclonal antibody (mAb) and complex therapeutic protein manufacturing, which enables important improvements to the […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/05/cytena.png 332 1123 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-05-16 12:29:432022-05-16 12:29:57CYTENA and ExcellGene to develop automated work-flows for biotherapeutics cell line development
codexis seqwell

Codexis and seqWell announce partnership to accelerate commercialization of seqWell’s genomics workflow solutions

, 16 May 2022/in E-News /by panglobal

Codexis and seqWell have announced the initiation of a strategic partnership and investment to accelerate the commercialization of seqWell’s genomics workflow solutions. Codexis, a leading enzyme engineering company enabling the promise of synthetic biology, and seqWell, a developer of transformative library preparation products for demanding genomics applications, plan to collaborate on using Codexis’ CodeEvolver platform […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/05/codexis_seqwell.jpg 542 770 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-05-16 12:27:152022-05-16 12:27:15Codexis and seqWell announce partnership to accelerate commercialization of seqWell’s genomics workflow solutions
biotium 5 22

Biotium acquires CAT5 FFPE RNA/DNA extraction technology from Cell Data Sciences

, 16 May 2022/in E-News /by panglobal

Biotium, a supplier of cutting-edge life science reagents, has acquired Cell Data Sciences RNAstorm and DNAstorm kits for RNA/DNA extraction. Biotium, which previously distributed the Cell Data Sciences kits, will now be their sole manufacturer. The extraction kits will be offered from the Biotium website and authorized distributors.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/05/biotium_5_22.jpg 1920 1280 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-05-16 12:24:522022-05-16 12:24:52Biotium acquires CAT5 FFPE RNA/DNA extraction technology from Cell Data Sciences
Arctoris

Arctoris and Evariste Technologies form a joint venture to identify novel small molecule cMET Inhibitors for Non-Small Cell Lung Cancer

, 16 May 2022/in E-News /by panglobal

Arctoris, a tech-enabled biopharma company, and Evariste Technologies, an AI-drug discovery company, have formed a joint venture to identify novel small molecule kinase inhibitors for treatment of patients with Non-Small Cell Lung Cancer (NSCLC). 

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/05/Arctoris.jpg 540 960 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-05-16 12:22:592022-05-16 12:22:59Arctoris and Evariste Technologies form a joint venture to identify novel small molecule cMET Inhibitors for Non-Small Cell Lung Cancer
Thermo Scientific Cascadion SM Clinical Analyzer

Thermo Scientific to connect its Cascadion SM Clinical Analyzer to Inpeco’s Flex Lab laboratory automation system

automation, laboratory automation system, 20 April 2022/in Product News, E-News /by panglobal

Thermo Fisher Scientific and Inpeco have agreed to develop connectivity between the Thermo Scientific Cascadion SM Clinical Analyzer and the Inpeco FlexLab laboratory automation system (LAS). This interface will enable primary tubes on the Inpeco LAS to be transported to the Cascadion analyzer for automated loading, pre-treatment, and analysis.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/04/thermo-scientific-cascadion_2.png 588 939 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-04-20 10:24:552024-08-21 14:05:09Thermo Scientific to connect its Cascadion SM Clinical Analyzer to Inpeco’s Flex Lab laboratory automation system
KAISTbacteria

‘Fingerprint’ machine learning technique identifies different bacteria in seconds

, 23 March 2022/in E-News /by panglobal

Bacterial identification can take hours and often longer, precious time when diagnosing infections and selecting appropriate treatments. There may be a quicker, more accurate process according to researchers at KAIST (Korea Advanced Institute of Science and Technology). By teaching a deep learning algorithm to identify the “fingerprint” spectra of the molecular components of various bacteria, […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/03/KAISTbacteria.jpg 624 650 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-03-23 10:54:532022-03-23 10:54:53‘Fingerprint’ machine learning technique identifies different bacteria in seconds
shutterstock 1684913200v2

Global death toll of COVID-19 pandemic may be more than three times higher than official records

, 23 March 2022/in E-News /by panglobal

More than three times as many people may have died worldwide as a result of the pandemic than official COVID-19 death records suggest, according to an analysis published in The Lancet.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/03/shutterstock_1684913200v2.jpg 491 1000 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-03-23 10:52:572022-03-23 10:52:57Global death toll of COVID-19 pandemic may be more than three times higher than official records
shutterstock 1924512671v2

Finnish diagnostics pioneers Abacus Diagnostica, Kaivogen and Labrox join to form Uniogen

, 23 March 2022/in E-News /by panglobal

Three Finnish life science experts – Abacus Diagnostica, a frontrunner in molecular testing and rapid PCR test systems, Kaivogen, a specialist in immunoassays and antibody tests, and Labrox, an innovator of high technology laboratory instruments and diagnostic readers – have joined forces to form a global diagnostics pioneer. The name of the new company is […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/03/shutterstock_1924512671v2.jpg 563 1000 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-03-23 10:06:582022-03-23 10:06:58Finnish diagnostics pioneers Abacus Diagnostica, Kaivogen and Labrox join to form Uniogen
selux dollarv2

Selux Diagnostics raises additional $50 million in Series C funding round

, 23 March 2022/in E-News /by panglobal

Selux Diagnostics, which is leading a new era in personalized diagnostics to combat superbug infections and fight antibiotic resistance, has raised $50 million in Series C financing to support the U.S. commercial launch of its Next-Generation Phenotyping (NGP) rapid Antimicrobial Susceptibility Testing (AST) platform.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/03/selux_dollarv2.jpg 750 1000 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-03-23 10:04:432022-03-23 10:05:14Selux Diagnostics raises additional $50 million in Series C funding round
orbit discovery

Orbit Discovery and WuXi AppTec sign agreement to access peptide discovery and optimisation technologies

, 23 March 2022/in E-News /by panglobal

Orbit Discovery, a ground-breaking peptide discovery company, and WuXi AppTec, a leading provider of R&D and manufacturing services for the pharmaceutical and healthcare industries, have formed a partnership wherein Orbit will combine its leading peptide discovery platform and experience with WuXi AppTec’s down-stream capabilities.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2022/03/orbit_discovery.png 792 1026 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2022-03-23 10:02:402022-03-23 10:02:40Orbit Discovery and WuXi AppTec sign agreement to access peptide discovery and optimisation technologies
Page 57 of 228«‹5556575859›»
Bio-Rad - Preparing for a Stress-free QC Audit

Latest issue of Clinical laboratory

November 2025

CLi Cover nov 2025
14 January 2026

CHITOSE and FUJIFILM Biosciences announce strategic alliance for biopharmaceutical production

14 January 2026

ProteoNic licenses vector technology for antibody manufacturing consortium

14 January 2026

ProBioGen partners with Spica Therapeutics for ST101 development

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics

Sign up today
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
clinlab logo blackbg 1

Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com

PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Subscribe now!

Become a reader.

Free subscription